VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 360.55 EUR -1.96%

Market Cap: €43.1B

V	Vertex Pharmaceuticals Inc XMUN:VX1	US
	Chocoladefabriken Lindt & Spruengli AG F:LSPP	CH
T	Travelers Companies Inc XETRA:PA9	US
A	Airbus SE XBER:AIRA	NL
A	ASML Holding NV XHAM:ASME	NL
T	Tenet Healthcare Corp XMUN:THC1	US
S	Sumitomo Electric Industries Ltd XMUN:SMO	JP
M	Mastercard Inc XHAM:M4I	US
C	CVB Financial Corp F:BCV	US
E	Equifax Inc F:EFX	US
S	Sumitomo Electric Industries Ltd OTC:SMTOY	JP
M	Mastercard Inc XBER:M4I	US
H	HCA Healthcare Inc F:2BH	US
S	Stryker Corp XBER:SYK	US
A	Advanced Micro Devices Inc DUS:AMD	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

42%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

33%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 33%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

19%

Declining Free Cash Flow Margin

42% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

Declining ROIC

50% > 27%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.